logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 20 of 67 Items
Showing 1 - 20 of 67 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Slide Presentation

Antibiogo as an innovative solution to detect antimicrobial resistance: from an operational need to a CE-marked diagnostic test available for low-income and middle-income countries

Rapoud D, Cramer E, Al Asmar M, Sagara F, Ndiaye B,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Video

Antibiogo as an innovative solution to detect antimicrobial resistance: from an operational need to a CE-marked diagnostic test available for low-income and middle-income countries

Malou N
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Abstract

Interim results of the multi-site incidence study of Lassa fever in West Africa

Camacho A
2023-06-08 • Epicentre Scientific Day Paris 2023
2023-06-08 • Epicentre Scientific Day Paris 2023
BACKGROUND
Lassa fever (LF), a haemorrhagic illness caused by the Lassa fever virus (LASV), is endemic in West Africa causing an estimated 300 000 to 500 000 cases and 5 000 fataliti...
Conference Material
|
Video

Interim results of the multi-site incidence study of Lassa fever in West Africa

Camacho A
2023-06-08 • Epicentre Scientific Day Paris 2023
2023-06-08 • Epicentre Scientific Day Paris 2023
Journal Article
|
Protocol

A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)–Study protocol

Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN,  et al.
2023-03-30 • PLOS One
2023-03-30 • PLOS One
BACKGROUND
Lassa fever (LF), a haemorrhagic illness caused by the Lassa fever virus (LASV), is endemic in West Africa and causes 5000 fatalities every year. The true prevalence and i...
Conference Material
|
Poster

Magnesium sulphate as an adjunct to treatment of tetanus in children

Goodyer J, Pont T, Lah ED, Mayronne S, Carreras I
2022-11-30 • MSF Paediatric Days 2022
2022-11-30 • MSF Paediatric Days 2022
Conference Material
|
Poster

Retrospective descriptive analysis of paediatric bacteraemia - Bardnesville Junction Hospital, Liberia

Goodyer J, Elbadawi H, Mayronne S, Lynch E, Michel J,  et al.
2022-11-30 • MSF Paediatric Days 2022
2022-11-30 • MSF Paediatric Days 2022
Journal Article
|
Research

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials

Simon JK, Kennedy SB, Mahon BE, Dubey SA, Grant-Klein RJ,  et al.
2022-10-05 • Vaccine
2022-10-05 • Vaccine
BACKGROUND
ERVEBO®, a live recombinant vesicular stomatitis virus (VSV) vaccine containing the Zaire ebolavirus glycoprotein (GP) in place of the VSV GP (rVSVΔG-ZEBOV-GP), was advanc...
Journal Article
|
Research

Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons—Liberia, 2004

Huhn GD, Brown J, Perea W, Berthe A, Otero H,  et al.
2006-02-06 • Vaccine
2006-02-06 • Vaccine
Yellow fever (YF) is a mosquito-borne vaccine-preventable disease with high mortality. In West Africa, low population immunity increases the risk of epidemic transmission. A cluster surv...
Journal Article
|
Research

'Atomic bombs' in Monrovia, Liberia: the identity and stigmatisation of Ebola survivors

Venables E
2017-06-01 • Anthropology in Action
2017-06-01 • Anthropology in Action
Survivors of the Ebola virus have been widely profiled as the success stories of the outbreak, yet they still face challenges relating to their identity and reintegration. A survivor’s b...
Journal Article
|
Short Report

Possible sexual transmission of Ebola virus - Liberia, 2015

Christie A, Davies-Wayne GJ, Cordier-Lassalle T, Blackley DJ, Laney AS,  et al.
2015-05-08 • Morbidity and Mortality Weekly Report
2015-05-08 • Morbidity and Mortality Weekly Report
Journal Article
|
Letter

Shedding of Ebola Virus in an Asymptomatic Pregnant Woman

Akerlund E, Prescott JB, Tampellini L
2015-06-18 • New England Journal of Medicine
2015-06-18 • New England Journal of Medicine
Journal Article
|
Research

Provision of antiretroviral treatment in conflict settings: the experience of Médecins Sans Frontières

O'Brien DP, Venis S, Greig J, Shanks L, Ellman T,  et al.
2010-06-17 • Conflict and Health
2010-06-17 • Conflict and Health
INTRODUCTION
Many countries ravaged by conflict have substantial morbidity and mortality attributed to HIV/AIDS yet HIV treatment is uncommonly available. Universal access to HIV car...
Journal Article
|
Short Report

Evidence for a decrease in transmission of Ebola virus — Lofa County, Liberia, June 8–November 1, 2014

Sharma A, Heijenberg N, Peter C, Bolongei J, Reeder B,  et al.
2014-11-14 • Morbidity and Mortality Weekly Report
2014-11-14 • Morbidity and Mortality Weekly Report
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?
Lofa County in Liberia has one of the highest numbers of reported cases of Ebola virus disease (Ebola) in West Africa. Government health offic...
Journal Article
|
Commentary

Clinical Field Research in a Post-conflict Setting

Boggero M
2010-10-01 • Global Policy
2010-10-01 • Global Policy
Journal Article
|
Research

Psychological distress among Ebola survivors discharged from an Ebola treatment unit in Monrovia, Liberia - a qualitative study

Rabelo I, Lee VS, Fallah MP, Massaquoi M, Evlampidou I,  et al.
2016-07-04 • Frontiers in Public Health
2016-07-04 • Frontiers in Public Health
INTRODUCTION
A consequence of the West Africa Ebola outbreak 2014–2015 was the unprecedented number of Ebola survivors discharged from the Ebola Treatment Units (ETUs). Liberia alone...
Journal Article
|
Research

Survivors' Perceptions of Public Health Messages During an Ebola Crisis in Liberia and Sierra Leone: An Exploratory Study

Schwerdtle PN, De Clerck V, Plummer V
2017-09-20 • Nursing and Health Sciences
2017-09-20 • Nursing and Health Sciences
The outbreak of Ebola virus disease in Guinea, Liberia, and Sierra Leone was the largest epidemic of Ebola ever recorded. The healthcare workforce was diminished and exhausted as the reg...
Journal Article
|
Research

Plasmodium parasitemia associated with increased survival in Ebola virus-infected patients

Rosenke K, Adjemian J, Munster VJ, Marzi A, Falzarano D,  et al.
2016-08-15 • Clinical Infectious Diseases
2016-08-15 • Clinical Infectious Diseases
BACKGROUND
The ongoing Ebola outbreak in West Africa has resulted in 28 646 suspected, probable, and confirmed Ebola virus infections. Nevertheless, malaria remains a large public he...
Journal Article
|
Research

Clinical chemistry of patients with Ebola in Monrovia, Liberia

de Wit E, Kramer S, Prescott JB, Rosenke K, Falzarano D,  et al.
2016-07-28 • Journal of Infectious Diseases
2016-07-28 • Journal of Infectious Diseases
The development of point-of-care clinical chemistry analyzers has enabled the implementation of these ancillary tests in field laboratories in resource-limited outbreak areas. The Eterna...
Journal Article
|
Commentary

A tale of two cities: restoring water services in Kabul and Monrovia

Pinera JF, Reed RA
2009-07-27 • Disasters
2009-07-27 • Disasters
Kabul and Monrovia, the respective capitals of Afghanistan and Liberia, have recently emerged from long-lasting armed conflicts. In both cities, a large number of organisations took part...